Laura King Joins Tactile Medical's Board of Directors
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), known for its commitment to providing advanced therapies for individuals with chronic disorders, has made a significant addition to its leadership team. The company is excited to announce the appointment of Laura King to its Board of Directors. This strategic decision, effective immediately, also includes her participation in the Audit and Compliance & Reimbursement Committees.
A Seasoned Healthcare Professional
Ms. King’s professional journey is marked by over two decades of experience at General Electric Company (GE), where she excelled in various leadership roles. Notably, she served as President & CEO of GE Healthcare’s Global Interventional Business. In that capacity, she was instrumental in promoting clinical solutions for minimally invasive procedures in key areas such as cardiology and interventional radiology. Her adeptness at navigating the complexities of healthcare has established her as a respected figure in the industry.
Innovative Contributions to Healthcare
Currently, Ms. King is the co-founder and CEO of BiaCure, Inc., an emerging company focused on developing effective treatments for nail fungus. Prior to this, she co-founded Elucent Medical, creating impactful solutions for breast cancer treatment through a real-time surgical navigation platform. Her leadership at NeuWave Medical further underscores her capabilities, where she oversaw the creation of a minimally invasive system for soft tissue microwave ablation, later acquired by Johnson & Johnson’s MedTech division.
Impact on Tactile Medical’s Mission
The Chairman of the Board, Bill Burke, expressed enthusiasm about Ms. King joining the team, noting, “We are thrilled to have Laura join our Board of Directors. Tactile will benefit from her considerable experience leading healthcare companies that develop innovative technologies to improve patient care.” As Tactile Medical continues to expand its reach in offering therapies for conditions like lymphedema and chronic pulmonary disease, Ms. King's expertise is expected to play a key role in shaping future strategies.
About Tactile Medical
Tactile Medical is dedicated to enhancing the quality of life for individuals grappling with chronic conditions such as lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease. The company has established itself as a leader in at-home therapy solutions, working closely with clinicians to support clinical evidence, increase awareness, and improve access to healthcare. This collaborative approach has resulted in better care for thousands of patients annually, helping them manage their conditions from the comfort of their homes.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
Frequently Asked Questions
What is the significance of Laura King's appointment?
Laura King's appointment to Tactile Medical's Board brings extensive healthcare experience and leadership skills, which are essential as the company seeks to further enhance patient care solutions.
What previous roles has Laura King held?
Laura King has held senior roles at GE, including President & CEO of GE Healthcare’s Global Interventional Business, and she has also co-founded BiaCure and Elucent Medical.
How does Tactile Medical support patients?
Tactile Medical provides innovative at-home therapies for chronic conditions, helping patients manage their health conditions and improve quality of life effectively.
What therapeutic areas does Tactile Medical focus on?
The company focuses on areas including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease, striving to offer impactful therapies for these conditions.
How does Tactile Medical collaborate with clinicians?
Tactile Medical partners with clinicians to expand clinical evidence, raise awareness, and improve access to care, which ultimately reduces healthcare costs and enhances patient outcomes.
